ATE322498T1 - Stabilisierte ascorbinsäure -3- phosphat- derivate - Google Patents

Stabilisierte ascorbinsäure -3- phosphat- derivate

Info

Publication number
ATE322498T1
ATE322498T1 AT01961047T AT01961047T ATE322498T1 AT E322498 T1 ATE322498 T1 AT E322498T1 AT 01961047 T AT01961047 T AT 01961047T AT 01961047 T AT01961047 T AT 01961047T AT E322498 T1 ATE322498 T1 AT E322498T1
Authority
AT
Austria
Prior art keywords
acid residues
ascorbic acid
alkyl
phosphate derivatives
stabilized ascorbic
Prior art date
Application number
AT01961047T
Other languages
English (en)
Inventor
Vladimir Babtsov
Yury Shapiro
Emma Kvitnitsky
Valery Belakhov
Original Assignee
Tagra Biotechnologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tagra Biotechnologies Ltd filed Critical Tagra Biotechnologies Ltd
Application granted granted Critical
Publication of ATE322498T1 publication Critical patent/ATE322498T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
AT01961047T 2001-07-26 2001-07-26 Stabilisierte ascorbinsäure -3- phosphat- derivate ATE322498T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2001/000690 WO2003010173A1 (en) 2001-07-26 2001-07-26 Stabilized derivatives of ascorbic acid -3-phosphate

Publications (1)

Publication Number Publication Date
ATE322498T1 true ATE322498T1 (de) 2006-04-15

Family

ID=11043074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01961047T ATE322498T1 (de) 2001-07-26 2001-07-26 Stabilisierte ascorbinsäure -3- phosphat- derivate

Country Status (7)

Country Link
US (1) US7045546B2 (de)
EP (1) EP1409494B1 (de)
JP (1) JP4991088B2 (de)
AT (1) ATE322498T1 (de)
DE (1) DE60118625T2 (de)
ES (1) ES2261458T3 (de)
WO (1) WO2003010173A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004232556A1 (en) * 2003-04-21 2004-11-04 Tagra Biotechnologies Ltd. Stabilized derivatives of ascorbic acid
FR2978963A1 (fr) 2011-08-11 2013-02-15 Ascorbix Nouveaux derives des furanones et composition pharmaceutique les contenant
CA2881091A1 (en) * 2012-08-06 2014-02-13 South Dakota Board Of Regents Ascorbic acid-eluting implantable medical devices, systems, and related methods
WO2015048121A1 (en) * 2013-09-25 2015-04-02 University Of Florida Research Foundation, Inc. Vitamin c prodrugs and uses thereof
GB2519972A (en) 2013-11-01 2015-05-13 Innospec Ltd Detergent compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1573872A (de) * 1966-12-10 1969-07-11
US3671549A (en) * 1970-03-05 1972-06-20 Merck & Co Inc Process for preparing ascorbyl-3-phosphate and salts thereof
RO86439B (ro) * 1982-01-15 1985-03-31 Eli Lilly And Company Procedeu pentru prepararea unor derivati de acid ascorbic
JP2540295B2 (ja) * 1985-04-23 1996-10-02 花王株式会社 アスコルビン酸誘導体
FR2580644B1 (fr) * 1985-04-23 1990-01-12 Kao Corp Derives de l'acide ascorbique
JPH01228978A (ja) * 1988-03-09 1989-09-12 Nippon Hai Potsukusu:Kk アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
CA2169629C (en) * 1993-08-16 2002-06-11 Jong Y. Lee Human erythropoietin receptor fragment and antibodies thereto
US5885574A (en) * 1994-07-26 1999-03-23 Amgen Inc. Antibodies which activate an erythropoietin receptor
AU6163196A (en) * 1995-06-07 1996-12-30 Smithkline Beecham Corporation Method for obtaining receptor agonist antibodies
EP0875246A1 (de) * 1997-04-04 1998-11-04 Showa Denko Kabushiki Kaisha Pharmazeutische Zusammensetzung aus Ascorbinsäurederivate zur Behandlung von Krebs
IT1291291B1 (it) 1997-04-30 1999-01-07 Chemedica Sa Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare

Also Published As

Publication number Publication date
HK1063473A1 (en) 2004-12-31
WO2003010173A1 (en) 2003-02-06
DE60118625D1 (de) 2006-05-18
DE60118625T2 (de) 2007-02-22
US7045546B2 (en) 2006-05-16
ES2261458T3 (es) 2006-11-16
JP2004536872A (ja) 2004-12-09
JP4991088B2 (ja) 2012-08-01
EP1409494A1 (de) 2004-04-21
EP1409494B1 (de) 2006-04-05
US20040242544A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
MXPA04001323A (es) Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
YU57603A (sh) Inhibitori fosfodiesteraze 4
ATE23947T1 (de) Haarshampoo-zusammensetzung.
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
WO1997046231B1 (en) Oxa acids and related compounds for treating skin conditions
ATE310152T1 (de) Verdickte säure zusammensetzungen und ihre verwendungen
PT787726E (pt) Novo composto, processo para a sua producao e agente tumoral
IL160045A0 (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
WO2004094369A3 (en) Stabilized derivatives of ascorbic acid
MY117789A (en) Pyrroloquinolones as antiviral agents
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
TW200512333A (en) Aqueous solutions of fluorescent whitening agents
BG104617A (en) Novel naphthyl-substituted and anilide-substituted sulfonamides
DE60118625D1 (de) Stabilisierte ascorbinsäure -3- phosphat- derivate
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
MXPA05013499A (es) Composiciones de enjuague bucal que contienen sales de n-acil-arginina alquil ester.
HRP20031055B1 (hr) Novi imunomodulirajući spojevi
HRP20010798B1 (hr) Postupci priprave pesticidnih međuprodukata
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
EP1378502A4 (de) Kettenförmiger oligomilchsäureester
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
MX9703841A (es) Composiciones blanqueadoras espesadas, metodo de uso y procedimiento para hacer las mismas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties